Skip to content
Open access

Reproductive factors and prognostic risk stratification in breast cancer: A single-centre study from Kerala with the PC-RISK-5 scoring system

Sep 2026 · South Asian Journal of Cancer · Vol 15, pp. 228-234 · 0 citations · 13 references

TL;DR

Later menopausal age was the notable exception, associated with higher prognostic risk and nodal involvement, consistent with prolonged oestrogen exposure, and reproductive factors overall showed no significant association with molecular subtype, grade, or survival.

Abstract

To examine the associations between reproductive factors — parity, lactation duration, and menopausal age — and tumour characteristics, molecular subtype, and PC-RISK-5 prognostic scores in women with breast cancer from a tertiary centre in Kerala, India. This retrospective cohort study included 221 women with invasive breast carcinoma diagnosed between January 2015 and June 2016 at a tertiary centre in Kerala, India. Molecular subtyping followed the St Gallen 2013 framework (Luminal A defined as Ki-67 <20%; HER2 3+ only). The PC-RISK-5 score assigned one point each for age >60 years, Ki-67 >30%, histological grade ≥II, lymph node positivity, and HER2 (IHC 2+/3+). Patients were stratified into three age bands (≤39, 40–65, >65 years). Associations were assessed using chi-squared, Kruskal–Wallis, and Mann–Whitney tests. Overall survival was analysed using Kaplan–Meier estimates with log-rank comparison. A two-sided p < 0.05 was considered statistically significant. Among 221 women (mean age 55.7 years), invasive ductal carcinoma predominated (93.7%). Later menopausal age was associated with higher PC-RISK-5 scores (mean 2.27, 2.86, and 3.00 across <42, 42–50, and >50 years; p = 0.028) and with greater nodal positivity (19%, 46%, and 57%; p = 0.041). PC-RISK-5 scores differed significantly across molecular subtypes ( p = 0.0003), being highest in HER2-driven tumours. Lactation duration showed a non-significant trend toward lower triple-negative proportion with longer duration (25.9% to 14.9%; p = 0.32). Parity, age at first childbirth, and reproductive factors overall showed no significant association with molecular subtype, grade, or survival. In this Kerala cohort, most reproductive factors were not significantly associated with tumour biology or outcome. Later menopausal age was the notable exception, associated with higher prognostic risk and nodal involvement, consistent with prolonged oestrogen exposure. PC-RISK-5 scores varied with molecular subtype, although this partly reflects shared components.

Read PDF

Similar papers

Open access Aug 2026

Ten-year survival of women with invasive breast cancer by stage, molecular subtype, and grade combined: a population-based study

Abstract Background Stage at diagnosis, histologic grade, and molecular subtypes are established prognostic indicators for women with breast cancer (BC), but their impact on population-based survival estimates is poorly documented. This study assessed long-term BC survival trends according to these factors. Methods We...

Fabiola Giudici, D. Serraino, F. Puglisi et al. · 0 citations
Open access Oct 2026

HER2 Status in Breast Cancer in Relation to Age and Tumor Category: A Cross-Sectional Clinicopathological Study from Karbala, Iraq

Background: Human epidermal growth factor receptor 2 (HER2) overexpression defines an aggressive, biologically distinct subset of breast carcinomas with critical therapeutic relevance. Epidemiological and pathological profiles from central Iraq, particularly Karbala Province, re- main scarce. This study evaluates HER2...

Bahaa Aldeen Abdulrahman Hadi · 0 citations
Open access Oct 2026

PROGNOSTIC RISK SCALE FOR MORTALITY IN BREAST CANCER

Relevance: Breast cancer is the most common malignancy in women and one of the leading causes of cancer-related mortality. Despite the availability of clinical and biological prognostic factors, developing simple, clinically applicable risk stratification tools remains an important challenge. The study aimed to iden...

I. Novikov, S. Yessentayeva, V. Makarov et al. · 0 citations
Open access Jan 2023

Prognostic comparison between male and female breast cancer: a population-based SEER database study.

BACKGROUND Male breast cancer (MBC) is extremely rare. This research sought to analyze the distinctions in clinical features and prognostic outcomes between male and female breast cancer (FBC), and to further develop the nomogram to estimate overall survival (OS) among MBC patients. METHODS This study extracted data...

Yong Chen, Hui Wang · 0 citations
Open access Sep 2026

Sentinel Lymph Node Positivity by Tumour Grade in Older Women With Breast Cancer: A Cross-Verified Retrospective Cohort Study

Background: The Choosing Wisely campaign and several randomised trials have questioned the routine use of sentinel lymph node biopsy (SLNB) in older women with early-stage, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, given the low rate of axillary nodal involvement...

Raafat Mady, Omar Mady, Maryam Nazim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.